Managed key accounts by providing maximum value to customers within Histology, IHC Advanced Staining and Digital Pathology2023 – Achieved $18.1M sales against a $15.3M target; #1 ranked (out of 16) thru Nov and forecasting top ranking for third time in four years2022 – Managed $17M territory; exceeded annual consumables goal; organized & led a multi-city Roadshow promoting newly launched instrumentation within IHC & tissue processing2021 - #1 Ranking (out of 10) achieving ~$20M revenue, 74% YOY growth & 129% PTP; selected for People Leader Development Program - completed "Crucial Conversations", "Problem-Solving Process" and "Speed of Trust" trainings2020 - Earned President's Club award and #1 ranking (out of 10) achieving $11.5M revenue, 9% YOY growth & 108% PTP

Presented the T2 value proposition (improved outcomes, stewardship and cost of sepsis management) to Sepsis and Stewardship Committees, focusing on changing the paradigm of sepsis management.Executed contract with health system, providing T2Dx instrument with T2Candida panel, projecting $200,000 annual revenue (2X of existing territory sales).

Key account management/instrument specialist role, focused on increasing revenue for the Alere i Molecular platform.2017 - Ranked #3 nationally on molecular team. Increased region’s Alere i portfolio revenue from $3M to $6.3M (110% YOY growth), selling Molecular testing for Influenza A&B, Strep A and RSVLead region’s molecular strategy by coaching 13 Account Executives (including 6 new reps) on best practices pertaining to selling Alere i solution.

Managed IDN and National Account relationships in the Western US (13 states) by engaging key supply chain decision-makers, in collaboration with laboratory personnel. 2014 - Earned President's Club award and #1 ranking on Health System Sales Team generating $2.25M in revenue (14% YOY growth) 2015 - Ranked #1 on Health Systems team in private label sales Negotiated and signed contract with Child Health Corporation of America (encompassing 42 Children’s Hospitals), a supply chain aggregation group thru Vizient, saving members more than 15% on rapid testing Partnered with Regional Purchasing Coalitions, GPO Sales Executives and Distributor – Health System Executives to present business case for standardizing rapid diagnostic testing menu

Changed modality of how providers tested for and diagnosed Bacterial Vaginosis and Trichomonas, improving sales by more than 100%, year over year, from 2010-20132012 - Ranked #2 in the Western US regionIncreased sales in territory, by 11% - 38%, year over year, from 2010 – 2013

Managed a $2.25 million dollar territory, increasing revenue 162% from the previous year